Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93


Patent Foramen Ovale (PFO), Personality Traits, and Iterative Decompression Sickness. Retrospective Analysis of 209 Cases.

Lafère P, Balestra C, Caers D, Germonpré P.

Front Psychol. 2017 Aug 2;8:1328. doi: 10.3389/fpsyg.2017.01328. eCollection 2017.


Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.

Van Der Steen N, Mentens Y, Ramael M, Leon LG, Germonpré P, Ferri J, Gandara DR, Giovannetti E, Peters GJ, Pauwels P, Rolfo C.

Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30197-3. doi: 10.1016/j.cllc.2017.06.010. [Epub ahead of print] Review.


Objective vs. Subjective Evaluation of Cognitive Performance During 0.4-MPa Dives Breathing Air or Nitrox.

Germonpré P, Balestra C, Hemelryck W, Buzzacott P, Lafère P.

Aerosp Med Hum Perform. 2017 May 1;88(5):469-475. doi: 10.3357/AMHP.4608.2017.


Inhaled treatment of COPD: a Delphi consensus statement.

Ninane V, Corhay JL, Germonpré P, Janssens W, Joos GF, Liistro G, Vincken W, Gurdain S, Vanvlasselaer E, Lehouck A.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 6;12:793-801. doi: 10.2147/COPD.S125564. eCollection 2017.


Preconditioning to Reduce Decompression Stress in Scuba Divers.

Germonpré P, Balestra C.

Aerosp Med Hum Perform. 2017 Feb 1;88(2):114-120. doi: 10.3357/AMHP.4642.2017.


Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer.

Van Der Steen N, Deben C, Deschoolmeester V, Wouters A, Lardon F, Rolfo C, Germonpré P, Giovannetti E, Peters GJ, Pauwels P.

World J Clin Oncol. 2016 Dec 10;7(6):425-432. doi: 10.5306/wjco.v7.i6.425.


Pre-dive Whole-Body Vibration Better Reduces Decompression-Induced Vascular Gas Emboli than Oxygenation or a Combination of Both.

Balestra C, Theunissen S, Papadopoulou V, Le Mener C, Germonpré P, Guerrero F, Lafère P.

Front Physiol. 2016 Nov 30;7:586. eCollection 2016.


Do Environmental Conditions Contribute to Narcosis Onset and Symptom Severity?

Lafère P, Balestra C, Hemelryck W, Guerrero F, Germonpré P.

Int J Sports Med. 2016 Dec;37(14):1124-1128. Epub 2016 Oct 13.


Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.

Mutluoglu M, Uzun G, Bennett M, Germonpré P, Smart D, Mathieu D.

Diving Hyperb Med. 2016 Sep;46(3):133-134.


Correlation between Patent Foramen Ovale, Cerebral "Lesions" and Neuropsychometric Testing in Experienced Sports Divers: Does Diving Damage the Brain?

Balestra C, Germonpré P.

Front Psychol. 2016 May 11;7:696. doi: 10.3389/fpsyg.2016.00696. eCollection 2016.


Cutis Marmorata skin decompression sickness is a manifestation of brainstem bubble embolization, not of local skin bubbles.

Germonpre P, Balestra C, Obeid G, Caers D.

Med Hypotheses. 2015 Dec;85(6):863-9. doi: 10.1016/j.mehy.2015.09.022. Epub 2015 Sep 28.


Persistent (patent) foramen ovale (PFO): implications for safe diving.

Germonpré P.

Diving Hyperb Med. 2015 Jun;45(2):73-4.


Association of microparticles and neutrophil activation with decompression sickness.

Thom SR, Bennett M, Banham ND, Chin W, Blake DF, Rosen A, Pollock NW, Madden D, Barak O, Marroni A, Balestra C, Germonpre P, Pieri M, Cialoni D, Le PN, Logue C, Lambert D, Hardy KR, Sward D, Yang M, Bhopale VB, Dujic Z.

J Appl Physiol (1985). 2015 Sep 1;119(5):427-34. doi: 10.1152/japplphysiol.00380.2015. Epub 2015 Jul 2.


The effect of pre-dive ingestion of dark chocolate on endothelial function after a scuba dive.

Theunissen S, Balestra C, Boutros A, De Bels D, Guerrero F, Germonpré P.

Diving Hyperb Med. 2015 Mar;45(1):4-9.


Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).

Vansteenkiste J, Barlesi F, Waller CF, Bennouna J, Gridelli C, Goekkurt E, Verhoeven D, Szczesna A, Feurer M, Milanowski J, Germonpre P, Lena H, Atanackovic D, Krzakowski M, Hicking C, Straub J, Picard M, Schuette W, O'Byrne K.

Ann Oncol. 2015 Aug;26(8):1734-40. doi: 10.1093/annonc/mdv219. Epub 2015 May 4.


ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.

Rolfo C, Passiglia F, Castiglia M, Raez LE, Germonpre P, Gil-Bazo I, Zwaenepoel K, De Wilde A, Bronte G, Russo A, Van Meerbeeck JP, Van Schil P, Pauwels P.

Transl Lung Cancer Res. 2014 Aug;3(4):250-61. doi: 10.3978/j.issn.2218-6751.2014.03.01. Review.


Rapid-onset adult respiratory distress syndrome after activated charcoal aspiration. A pitch-black tale of a potential to kill.

De Weerdt A, Snoeckx A, Germonpré P, Jorens PG.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):344-5. doi: 10.1164/rccm.201409-1607IM. No abstract available.


Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus.

Cappuzzo F, Moro-Sibilot D, Gautschi O, Boleti E, Felip E, Groen HJ, Germonpré P, Meldgaard P, Arriola E, Steele N, Fox J, Schnell P, Engelsberg A, Wolf J.

Lung Cancer. 2015 Feb;87(2):89-95. doi: 10.1016/j.lungcan.2014.12.010. Epub 2014 Dec 18. Review.


Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.

Moran T, Wei J, Cobo M, Qian X, Domine M, Zou Z, Bover I, Wang L, Provencio M, Yu L, Chaib I, You C, Massuti B, Song Y, Vergnenegre A, Lu H, Lopez-Vivanco G, Hu W, Robinet G, Yan J, Insa A, Xu X, Majem M, Chen X, de Las Peñas R, Karachaliou N, Sala MA, Wu Q, Isla D, Zhou Y, Baize N, Zhang F, Garde J, Germonpre P, Rauh S, ALHusaini H, Sanchez-Ronco M, Drozdowskyj A, Sanchez JJ, Camps C, Liu B, Rosell R; Spanish Lung Cancer Group; French Lung Cancer Group; Comprehensive Cancer Centre of Drum Tower Hospital in Nanjing.

Ann Oncol. 2014 Nov;25(11):2147-55. doi: 10.1093/annonc/mdu389. Epub 2014 Aug 27.


Supplemental Content

Loading ...
Support Center